BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.
Quote | Biondvax Pharms Ltd Ord (OTCMKTS:BVAXF)
Last: | $0.0537 |
---|---|
Change Percent: | 3.9% |
Open: | $0.0503 |
Close: | $0.0537 |
High: | $0.05378 |
Low: | $0.04745 |
Volume: | 172,000 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Biondvax Pharms Ltd Ord (OTCMKTS:BVAXF)
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or the " Company ") announ...
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that the United ...
Message Board Posts | Biondvax Pharms Ltd Ord (OTCMKTS:BVAXF)
Subject | By | Source | When |
---|---|---|---|
https://twitter.com/spactraderintra/status/1579856532732534784?s=61&t=f7JpLILgxJ | DEATHZAP_5167 | investorshub | 10/12/2022 8:16:55 AM |
$BVAXF has a monster lineup with an exciting | DEATHZAP_5167 | investorshub | 10/12/2022 8:15:36 AM |
$BVAXF Continues to trade green in a red | TommyBoyTrader9460 | investorshub | 10/10/2022 4:24:19 PM |
Most recent PRs read here. Alot of DD | DEATHZAP_5167 | investorshub | 10/10/2022 10:30:28 AM |
MEGA Research Collaboration w/ Ohio State University to | DEATHZAP_5167 | investorshub | 10/09/2022 8:40:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Biondvax Pharms Ltd Ord Company Name:
BVAXF Stock Symbol:
OTCMKTS Market:
Biondvax Pharms Ltd Ord Website:
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or the " Company ") announ...
BIOVAXYS ANNOUNCES ISSUANCE OF DPX RELATED PATENT FROM THE U.S. PATENT AND TRADEMARK OFFICE Canada NewsWire VANCOUVER, BC , July 23, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that the United ...
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor Canada NewsWire VANCOUVER, BC , July 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison , ...